Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

54.59
Delayed Data
As of Aug 18
 -0.64 / -1.16%
Today’s Change
40.58
Today|||52-Week Range
69.53
+10.98%
Year-to-Date

Today’s Trading

Previous close55.23
Today’s open54.50
Day’s range54.01 - 55.89
Volume343,889
Average volume (3 months)285,686
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-75.19%
Earnings growth (this year)+4.95%
Earnings growth (next 5 years)-17.04%
Revenue growth (last year)-34.35%
P/E ratioNM
Price/Sales1,601.64
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.22+1.79%
LOXOLoxo Oncology Inc+0.60+0.84%
IRWDIronwood Pharmaceuti...0.000.00%
HZNPHorizon Pharma PLC+0.17+1.29%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$1.36
Annual revenue (last year)$1.1M
Annual profit (last year)-$160.1M
Net profit margin-15,176.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gene G. Kinney
Chief Financial Officer
Tran B. Nguyen
Corporate headquarters
Dun Laoghaire, Dublin

Forecasts